BibTex RIS Cite

Eccrine porocarcinoma: A case report and literature review

Year 2007, Volume: 22 Issue: 4, 188 - 191, 01.05.2007

Abstract

Eccrine porocarcinoma is a rare malignant sweat gland tumor. The lower extremity represents the most common tumor site for this entity. Surgical excision seems to be the best treatment choice. The surgical margins should be free of tumor, otherwise a local recurrence is most likely. Regional lymph node dissection should be performed if there is evidence of lymphadenopathy. Here, we present clinical and pathological findings of a 69 years old woman diagnosed with eccrine porocarcinoma arising from the skin of the trunk.

References

  • 1. Whitt P, Whelchel J, Ruff T. Eccrine porocarcinoma. Ear Nose Throat J 1996;75(8):536-8.
  • 2. Pinkus H, Mehregan AH. Epidermotropic eccrine carcinoma. A case combining features of eccrine poroma and Paget’s dermatosis. Arch Dermatol 1963;88:597- 606.
  • 3. Mishima Y, Morioka S. Oncogenic differentiation of the intraepidermal eccrine sweat duct: eccrine poroma, poroepithelioma and porocarcinoma. Dermatologica 1969;138(4):238-50.
  • 4. Snow SN, Reizner GT. Eccrine porocarcinoma of the face. J Am Acad Dermatol 1992;27(2 Pt 2):306-11.
  • 5. Ritter AM, Graham RS, Amaker B, Broaddus WC, Young HF. Intracranial extension of an eccrine porocarcinoma. Case report and review of the literature. J Neurosurg 1999;90(1):138-40.
  • 6. Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma. A clinicopathologic study of 35 cases. Arch Dermatol 1983;119(2):104-14.
  • 7. Robson A, Greene J, Ansari N, Kim B, Seed PT, McKee PH, et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol 2001;25(6):710-20.
  • 8. Wi t t e n b e rg GP, Robertson DB, Solomon AR, Washington CV. Eccrine porocarcinoma treated with Mohs micrographic surgery: A report of five cases. Dermatol Surg 1999;25(11):911-3.
  • 9. Huet P, Dandurand M, Pignodel C, Guillot B. Metastasizing eccrine porocarcinoma: report of a case and review of the literature. J Am Acad Dermatol 1996;35(5 Pt 2):860-4.
  • 10. Arslan E, Tatar C, Aksoy A, Tutuncu N. De novo malignant eccrine poroma of the nose: a review of the midface as a location. Plast Reconstr Surg 2004;113(7):2227-9.
  • 11. Thompson JF, Uren RF. Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncol 2005;6(11):877-85.
  • 12. Bogner PN, Fullen DR, Lowe L, Paulino A, Biermann JS, Sondak VK, et al. Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma. Cancer 2003;97(9):2285-9.
  • 13. Plunkett TA, Hanby AM, Miles DW, Rubens RD. Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy. Ann Oncol 2001;12(3):411-4.
  • 14. Nabi HA, Zubeldia JM. Clinical applications of (18)FFDG in oncology. J Nucl Med Technol 2002;30(1):3-9.
  • 15.Cho SB, Roh MR, Yun M, Yun SK, Lee MG, Chung K Y. (18)F-fluorodeoxyglucose positron emission tomography detection of eccrine porocarcinoma. Br J Dermatol 2005;152(2):372-3.

Ekrin porokarsinom: Olgu sunumu ve literatür derlemesi

Year 2007, Volume: 22 Issue: 4, 188 - 191, 01.05.2007

Abstract

Ekrin porokarsinom, ekrin ter bezlerinden kaynaklanan nadir bir tümördür. Alt ekstremiteler en sık görüldüğü bölgedir. Cerrahi eksizyon en iyi tedavi seçeneği gibi görünmektedir. Cerrahi sınırların temiz olması lokal nüksleri önlemek açısından önemlidir. Lenf nodu tutulumu varsa bölgesel lenf nodu diseksiyonu yapılmalıdır. Biz, gövde cildinden kaynaklanan ekrin porokarsinom tanılı 69 yaşında bir kadın olgunun klinik ve patolojik özelliklerini sunuyoruz.

References

  • 1. Whitt P, Whelchel J, Ruff T. Eccrine porocarcinoma. Ear Nose Throat J 1996;75(8):536-8.
  • 2. Pinkus H, Mehregan AH. Epidermotropic eccrine carcinoma. A case combining features of eccrine poroma and Paget’s dermatosis. Arch Dermatol 1963;88:597- 606.
  • 3. Mishima Y, Morioka S. Oncogenic differentiation of the intraepidermal eccrine sweat duct: eccrine poroma, poroepithelioma and porocarcinoma. Dermatologica 1969;138(4):238-50.
  • 4. Snow SN, Reizner GT. Eccrine porocarcinoma of the face. J Am Acad Dermatol 1992;27(2 Pt 2):306-11.
  • 5. Ritter AM, Graham RS, Amaker B, Broaddus WC, Young HF. Intracranial extension of an eccrine porocarcinoma. Case report and review of the literature. J Neurosurg 1999;90(1):138-40.
  • 6. Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma. A clinicopathologic study of 35 cases. Arch Dermatol 1983;119(2):104-14.
  • 7. Robson A, Greene J, Ansari N, Kim B, Seed PT, McKee PH, et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol 2001;25(6):710-20.
  • 8. Wi t t e n b e rg GP, Robertson DB, Solomon AR, Washington CV. Eccrine porocarcinoma treated with Mohs micrographic surgery: A report of five cases. Dermatol Surg 1999;25(11):911-3.
  • 9. Huet P, Dandurand M, Pignodel C, Guillot B. Metastasizing eccrine porocarcinoma: report of a case and review of the literature. J Am Acad Dermatol 1996;35(5 Pt 2):860-4.
  • 10. Arslan E, Tatar C, Aksoy A, Tutuncu N. De novo malignant eccrine poroma of the nose: a review of the midface as a location. Plast Reconstr Surg 2004;113(7):2227-9.
  • 11. Thompson JF, Uren RF. Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncol 2005;6(11):877-85.
  • 12. Bogner PN, Fullen DR, Lowe L, Paulino A, Biermann JS, Sondak VK, et al. Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma. Cancer 2003;97(9):2285-9.
  • 13. Plunkett TA, Hanby AM, Miles DW, Rubens RD. Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy. Ann Oncol 2001;12(3):411-4.
  • 14. Nabi HA, Zubeldia JM. Clinical applications of (18)FFDG in oncology. J Nucl Med Technol 2002;30(1):3-9.
  • 15.Cho SB, Roh MR, Yun M, Yun SK, Lee MG, Chung K Y. (18)F-fluorodeoxyglucose positron emission tomography detection of eccrine porocarcinoma. Br J Dermatol 2005;152(2):372-3.
There are 15 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Mert Saynak This is me

Zafer Koçak This is me

Şemsi Altaner This is me

Alaattin Özen This is me

Ruşen Çoşar Alas This is me

Vuslat Yürüt Çaloğlu This is me

Burcu Üregen This is me

Sernaz Uzunoğlu This is me

Murat Çaloğlu This is me

Cem Uzal This is me

Publication Date May 1, 2007
Published in Issue Year 2007 Volume: 22 Issue: 4

Cite

APA Saynak, M., Koçak, Z., Altaner, Ş., Özen, A., et al. (2007). Ekrin porokarsinom: Olgu sunumu ve literatür derlemesi. Türk Onkoloji Dergisi, 22(4), 188-191.
AMA Saynak M, Koçak Z, Altaner Ş, Özen A, Alas RÇ, Çaloğlu VY, Üregen B, Uzunoğlu S, Çaloğlu M, Uzal C. Ekrin porokarsinom: Olgu sunumu ve literatür derlemesi. Türk Onkoloji Dergisi. May 2007;22(4):188-191.
Chicago Saynak, Mert, Zafer Koçak, Şemsi Altaner, Alaattin Özen, Ruşen Çoşar Alas, Vuslat Yürüt Çaloğlu, Burcu Üregen, Sernaz Uzunoğlu, Murat Çaloğlu, and Cem Uzal. “Ekrin Porokarsinom: Olgu Sunumu Ve literatür Derlemesi”. Türk Onkoloji Dergisi 22, no. 4 (May 2007): 188-91.
EndNote Saynak M, Koçak Z, Altaner Ş, Özen A, Alas RÇ, Çaloğlu VY, Üregen B, Uzunoğlu S, Çaloğlu M, Uzal C (May 1, 2007) Ekrin porokarsinom: Olgu sunumu ve literatür derlemesi. Türk Onkoloji Dergisi 22 4 188–191.
IEEE M. Saynak, “Ekrin porokarsinom: Olgu sunumu ve literatür derlemesi”, Türk Onkoloji Dergisi, vol. 22, no. 4, pp. 188–191, 2007.
ISNAD Saynak, Mert et al. “Ekrin Porokarsinom: Olgu Sunumu Ve literatür Derlemesi”. Türk Onkoloji Dergisi 22/4 (May 2007), 188-191.
JAMA Saynak M, Koçak Z, Altaner Ş, Özen A, Alas RÇ, Çaloğlu VY, Üregen B, Uzunoğlu S, Çaloğlu M, Uzal C. Ekrin porokarsinom: Olgu sunumu ve literatür derlemesi. Türk Onkoloji Dergisi. 2007;22:188–191.
MLA Saynak, Mert et al. “Ekrin Porokarsinom: Olgu Sunumu Ve literatür Derlemesi”. Türk Onkoloji Dergisi, vol. 22, no. 4, 2007, pp. 188-91.
Vancouver Saynak M, Koçak Z, Altaner Ş, Özen A, Alas RÇ, Çaloğlu VY, Üregen B, Uzunoğlu S, Çaloğlu M, Uzal C. Ekrin porokarsinom: Olgu sunumu ve literatür derlemesi. Türk Onkoloji Dergisi. 2007;22(4):188-91.